Actively Recruiting
Artificial Intelligence for Pathology Diagnosis and Prognosis Prediction of Lung Nodule Using Smartphone Photos
Led by Anhui Provincial Hospital · Updated on 2025-08-01
600
Participants Needed
3
Research Sites
N/A
Total Duration
On this page
Sponsors
A
Anhui Provincial Hospital
Lead Sponsor
T
The First Affiliated Hospital of Soochow University
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are developing and validating an artificial intelligence (AI) model that uses smartphone photos of removed lung tumor specimens to diagnose lung nodules and predict their prognosis. This study focuses on patients aged 20 to 75 years who are scheduled for lung surgery due to detected lung lesions seen on CT scans. The goal is to improve diagnosis and outcome predictions through AI analysis. The study observes participants undergoing surgery for pulmonary lesions identified by preoperative thin-section CT scans. The AI model is created and tested using smartphone images of the resected tumor specimens. There are no treatment interventions; instead, the research collects diagnostic data to evaluate the AI's performance. Participants will have their clinical and surgical information recorded. The main outcome measured is the area under the receiver operating characteristic curve, assessing the AI model's diagnostic accuracy over up to six months from enrollment. The study runs from June 2025 to October 2025 and involves monitoring the AI's ability to predict pathology and prognosis from specimen photos.
CONDITIONS
Brief Title
Artificial Intelligence for Pathology Diagnosis and Prognosis Prediction of Lung Nodule Using Smartphone Photos
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants scheduled for surgery for lung lesions detected by preoperative thin-section CT scans
- Age between 20 and 75 years
You will not qualify if you...
- Participants with incomplete clinical information
- Participants who have received anti-tumor therapy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day of surgery and hospital stay
Participants undergo surgery for lung lesions detected by preoperative CT scans, and immediate post-operative care is provided.
1 surgical visit and hospital stay
Duration - From surgery to pathology result availability
AI model analyzes smartphone photos of resected tumor specimens to assist in pathology diagnosis and prognosis prediction.
No additional visits required
Duration - Up to 6 months
Participants are monitored for outcomes related to lung nodule diagnosis and prognosis following surgery.
Follow-up visits as per routine clinical care
Trial Site Locations
Total: 3 locations
1
Anhui Provincial Hospital
Hefei, Anhui, China, 230000
Actively Recruiting
2
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China, 215000
Actively Recruiting
3
Ningbo First Hospital
Ningbo, Zhejiang, China, 315000
Actively Recruiting
Research Team
Y
Yifan Zhong, PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here